Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Leigh

Showing results (41-50 of 149) with videos related to

Pageof 15
Sort By:
Plos One|November 13, 2012
Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factorsIrene J Higginson, Wei Gao, Tariq Zaffer Saleem, et al.
Brain : a Journal of Neurology|May 20, 2026
CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survivalJohanna K Vallikivi, Maarten Kooyman, , et al.
Archives of Neurology|June 10, 2009
Defining survival as an outcome measure in amyotrophic lateral sclerosisPaul H Gordon, Philippe Corcia, Lucette Lacomblez, et al.
Neurobiology of Aging|October 30, 2016
Characterizing axonal myelination within the healthy population: a tract-by-tract mapping of effects of age and gender on the fiber g-ratioMara Cercignani, Giovanni Giulietti, Nick G Dowell, et al.
Journal of Neurology|December 7, 2007
Birth order and the genetics of amyotrophic lateral sclerosisUmesh Vivekananda, Clare Johnston, Diane McKenna-Yasek, et al.
Journal of Neurology|February 13, 2007
Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PETMartin R Turner, Alexander Hammers, Ammar Al-Chalabi, et al.
Annals of Medicine|October 31, 2022
Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patientsGreig Joilin, Elizabeth Gray, Alexander G Thompson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 6, 2016
A clinical tool for predicting survival in ALSJonathan A Knibb, Noa Keren, Anna Kulka, et al.
Human Mutation|November 21, 2002
D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotypeMatthew J Parton, Wendy Broom, Peter M Andersen, et al.
Neuroreport|April 10, 2004
Gigaxonin is associated with the Golgi and dimerises via its BTB domainValerie C Cullen, Janet Brownlees, Steven Banner, et al.
Pageof 15

Showing results (41-50 of 149) with videos related to

Sort By:
Pageof 15
Plos One|November 13, 2012
Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factorsIrene J Higginson, Wei Gao, Tariq Zaffer Saleem, et al.
Brain : a Journal of Neurology|May 20, 2026
CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survivalJohanna K Vallikivi, Maarten Kooyman, , et al.
Archives of Neurology|June 10, 2009
Defining survival as an outcome measure in amyotrophic lateral sclerosisPaul H Gordon, Philippe Corcia, Lucette Lacomblez, et al.
Neurobiology of Aging|October 30, 2016
Characterizing axonal myelination within the healthy population: a tract-by-tract mapping of effects of age and gender on the fiber g-ratioMara Cercignani, Giovanni Giulietti, Nick G Dowell, et al.
Journal of Neurology|December 7, 2007
Birth order and the genetics of amyotrophic lateral sclerosisUmesh Vivekananda, Clare Johnston, Diane McKenna-Yasek, et al.
Journal of Neurology|February 13, 2007
Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PETMartin R Turner, Alexander Hammers, Ammar Al-Chalabi, et al.
Annals of Medicine|October 31, 2022
Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patientsGreig Joilin, Elizabeth Gray, Alexander G Thompson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 6, 2016
A clinical tool for predicting survival in ALSJonathan A Knibb, Noa Keren, Anna Kulka, et al.
Human Mutation|November 21, 2002
D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotypeMatthew J Parton, Wendy Broom, Peter M Andersen, et al.
Neuroreport|April 10, 2004
Gigaxonin is associated with the Golgi and dimerises via its BTB domainValerie C Cullen, Janet Brownlees, Steven Banner, et al.
Pageof 15